KTTA CIK: 1841330

Pasithea Therapeutics Corp.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.17
FY22:
−14.6
FY23:
−12.8
FY24:
−13.9
FY25:
−15.2
Change from FY21 to FY25
millions USD
FY21:
−0.02
FY22:
−2.06
FY23:
0.08
FY24:
–
FY25:
0.01
Change from FY21 to FY25
millions USD
FY21:
55.9
FY22:
−3.21
FY23:
−3.73
FY24:
4.52
FY25:
63.5
millions USD
FY21:
52.7
FY22:
−19.8
FY23:
−16.8
FY24:
−9.41
FY25:
48.3
(positive)
Change from FY21 to FY23
millions USD
FY21:
−3.20
FY22:
−14.9
FY23:
−12.8
FY24:
–
FY25:
–

All amounts in millions USD Data source:SEC EDGAR